,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,104636,5281404,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,104636,5281404,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,104636,5281404,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,104636,5281404,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,104636,5281404,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,104636,5281404,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,357,2,1,,11111276,5281404,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
7,357,2,1,,11111277,5281404,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
8,410,1,5,,11111276,5281404,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
9,410,1,5,,11111277,5281404,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
10,410,1,5,,11113939,5281404,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
11,411,2,1,,11111276,5281404,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
12,411,2,1,,11111277,5281404,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
13,411,2,1,,11113939,5281404,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
14,422,1,5,,17405167,5281404,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
15,429,1,5,,17405167,5281404,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
16,429,1,5,,17405167,5281404,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
17,436,2,1,,17405167,5281404,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
18,444,1,1,,11111276,5281404,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
19,444,1,1,,11111277,5281404,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
20,445,3,1,,11111276,5281404,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
21,445,3,1,,11111277,5281404,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
22,445,3,1,,11113939,5281404,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
23,446,1,1,,11111276,5281404,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
24,446,1,1,,11111277,5281404,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
25,447,1,1,,11111276,5281404,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
26,447,1,1,,11111277,5281404,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
27,447,1,1,,11113939,5281404,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
28,448,1,2,,11111276,5281404,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
29,448,1,2,,11111277,5281404,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
30,448,1,2,,11113939,5281404,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
31,450,1,2,,11111276,5281404,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
32,450,1,2,,11111277,5281404,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
33,450,1,2,,11113939,5281404,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
34,451,1,2,,11111276,5281404,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
35,451,1,2,,11111277,5281404,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
36,451,1,2,,11113939,5281404,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
37,526,1,1,,11111276,5281404,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
38,526,1,1,,11111277,5281404,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
39,526,1,1,,11113939,5281404,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
40,530,1,1,,11111276,5281404,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
41,530,1,1,,11111277,5281404,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
42,530,1,1,,11113939,5281404,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
43,547,1,4,,17405167,5281404,Inactive,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
44,584,1,3,,11111276,5281404,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
45,584,1,3,,11111277,5281404,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
46,584,1,3,,11113939,5281404,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
47,585,1,4,,11111276,5281404,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
48,585,1,4,,11111277,5281404,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
49,585,1,4,,11113939,5281404,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
50,587,1,5,,11111276,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
51,587,1,5,,11111277,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
52,588,1,4,,11111276,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
53,588,1,4,,11111277,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
54,589,1,3,,11111276,5281404,Active,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
55,589,1,3,,11111277,5281404,Active,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
56,590,1,3,,11111276,5281404,Active,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
57,590,1,3,,11111277,5281404,Active,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
58,591,1,4,,11111276,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
59,591,1,4,,11111277,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
60,592,1,6,,11111276,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
61,592,1,6,,11111277,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
62,593,1,4,,11111276,5281404,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
63,593,1,4,,11111277,5281404,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
64,594,1,4,,11111276,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
65,594,1,4,,11111277,5281404,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
66,595,1,3,,11111276,5281404,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
67,595,1,3,,11111277,5281404,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
68,595,1,3,,11113939,5281404,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
69,596,1,2,,11111276,5281404,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
70,596,1,2,,11111277,5281404,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
71,596,1,2,,11113939,5281404,Inconclusive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
72,597,1,3,,11111276,5281404,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
73,597,1,3,,11111277,5281404,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
74,597,1,3,,11113939,5281404,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
75,603,1,2,,11111276,5281404,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
76,603,1,2,,11111277,5281404,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
77,603,1,2,,11113939,5281404,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
78,605,1,2,,11111276,5281404,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
79,605,1,2,,11111277,5281404,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
80,605,1,2,,11113939,5281404,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
81,607,1,3,,11111276,5281404,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
82,607,1,3,,11111277,5281404,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
83,607,1,3,,11113939,5281404,Inconclusive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
84,608,1,6,,11537965,5281404,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
85,662,1,1,,11111276,5281404,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
86,662,1,1,,11111277,5281404,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
87,662,1,1,,11113939,5281404,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
88,694,1,1,,17405167,5281404,Inactive,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
89,732,1,2,,17405167,5281404,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
90,875,1,2,,11111277,5281404,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
91,875,1,2,,11113939,5281404,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
92,879,1,2,,11113939,5281404,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
93,879,1,2,,11113939,5281404,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
94,880,2,1,,11111277,5281404,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
95,880,2,1,,11111277,5281404,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
96,880,2,1,,11113939,5281404,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
97,880,2,1,,11113939,5281404,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
98,880,2,1,,26747158,5281404,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
99,880,2,1,,26747158,5281404,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
100,880,2,1,,26752092,5281404,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
101,880,2,1,,26752092,5281404,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
102,880,2,1,,50104745,5281404,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
103,880,2,1,,50104745,5281404,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
104,880,2,1,,50104746,5281404,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
105,880,2,1,,50104746,5281404,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
106,881,2,2,,11111277,5281404,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
107,881,2,2,,11113939,5281404,Inactive,317373425.0,247.0,15.8489,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
108,883,1,3,,11111276,5281404,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
109,883,1,3,,11111277,5281404,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
110,883,1,3,,11113939,5281404,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
111,884,1,2,,11111277,5281404,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
112,884,1,2,,11113939,5281404,Active,13435386.0,1576.0,3.9811,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
113,885,1,2,,11111277,5281404,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
114,885,1,2,,11113939,5281404,Inactive,13435386.0,1576.0,3.9811,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
115,886,1,2,,11111276,5281404,Inconclusive,122921310.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
116,886,1,2,,11111276,5281404,Inconclusive,122921311.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
117,886,1,2,,11111277,5281404,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
118,886,1,2,,11111277,5281404,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
119,886,1,2,,11113939,5281404,Active,122921310.0,,25.1189,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
120,886,1,2,,11113939,5281404,Active,122921311.0,,25.1189,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
121,887,1,2,,11111277,5281404,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
122,887,1,2,,11113939,5281404,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
123,889,1,3,,11111277,5281404,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
124,889,1,3,,11113939,5281404,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
125,891,1,2,,11111276,5281404,Inconclusive,40805836.0,1565.0,31.6228,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
126,891,1,2,,11111277,5281404,Inconclusive,40805836.0,1565.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
127,891,1,2,,11113939,5281404,Active,40805836.0,1565.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
128,892,1,2,,11111277,5281404,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
129,892,1,2,,11113939,5281404,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
130,893,1,2,,11111277,5281404,Active,122921310.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
131,893,1,2,,11111277,5281404,Active,122921311.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
132,893,1,2,,11113939,5281404,Active,122921310.0,,25.1189,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
133,893,1,2,,11113939,5281404,Active,122921311.0,,25.1189,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
134,894,2,1,,11111277,5281404,Inconclusive,31542939.0,3248.0,12.5893,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
135,894,2,1,,11113939,5281404,Inconclusive,31542939.0,3248.0,35.4813,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
136,894,2,1,,26747158,5281404,Inconclusive,31542939.0,3248.0,28.1838,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
137,894,2,1,,50104745,5281404,Inconclusive,31542939.0,3248.0,31.6228,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
138,894,2,1,,50104746,5281404,Inconclusive,31542939.0,3248.0,22.3872,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
139,895,1,2,,11113939,5281404,Inconclusive,21620132.0,4790.0,1.9953,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
140,899,1,2,,11111276,5281404,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
141,899,1,2,,11111277,5281404,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
142,899,1,2,,11113939,5281404,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
143,900,1,3,,11111277,5281404,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
144,900,1,3,,11113939,5281404,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
145,901,1,2,,11111277,5281404,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
146,901,1,2,,11113939,5281404,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
147,902,1,2,,11111277,5281404,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
148,902,1,2,,11113939,5281404,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
149,910,1,2,,11113939,5281404,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
150,912,1,2,,11111276,5281404,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
151,912,1,2,,11111277,5281404,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
152,912,1,2,,11113939,5281404,Inconclusive,21392848.0,,1.9953,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
153,914,1,3,,11111276,5281404,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
154,914,1,3,,11111277,5281404,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
155,915,1,3,,11111276,5281404,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
156,915,1,3,,11111277,5281404,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
157,917,1,3,,11113939,5281404,Inactive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
158,918,1,3,,11113939,5281404,Inconclusive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
159,923,1,2,,11111277,5281404,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
160,923,1,2,,11113939,5281404,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
161,924,1,2,,11111277,5281404,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
162,924,1,2,,11113939,5281404,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
163,925,1,2,,11111276,5281404,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
164,925,1,2,,11111277,5281404,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
165,926,1,2,,11111276,5281404,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
166,926,1,2,,11111277,5281404,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
167,926,1,2,,11113939,5281404,Inconclusive,38016895.0,7253.0,25.1189,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
168,927,1,3,,11111277,5281404,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
169,927,1,3,,11113939,5281404,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
170,928,1,2,,11113939,5281404,Inconclusive,21620132.0,4790.0,1.9953,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
171,930,1,2,,11113939,5281404,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
172,938,1,2,,11111276,5281404,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
173,938,1,2,,11111277,5281404,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
174,938,1,2,,11113939,5281404,Inconclusive,38016895.0,7253.0,25.1189,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
175,940,1,2,,17405167,5281404,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
176,940,1,2,,26612111,5281404,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
177,943,1,2,,11113939,5281404,Inconclusive,18249941.0,25229.0,25.1189,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
178,944,1,2,,11113939,5281404,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
179,945,1,4,,11113939,5281404,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
180,954,1,2,,11113939,5281404,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
181,957,1,2,,11113939,5281404,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
182,958,1,2,,11113939,5281404,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
183,959,1,4,,11113939,5281404,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
184,992,1,3,,11113939,5281404,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
185,995,1,2,,11111277,5281404,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
186,995,1,2,,11113939,5281404,Inactive,66932916.0,5594.0,100.0,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
187,997,1,2,,11113939,5281404,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
188,998,1,2,,11113939,5281404,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
189,1030,2,1,,11111277,5281404,Inconclusive,30582681.0,216.0,11.2202,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
190,1030,2,1,,11113939,5281404,Inconclusive,30582681.0,216.0,28.1838,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
191,1030,2,1,,26747158,5281404,Inconclusive,30582681.0,216.0,31.6228,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
192,1030,2,1,,26752092,5281404,Inconclusive,30582681.0,216.0,25.1189,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
193,1030,2,1,,50104745,5281404,Inconclusive,30582681.0,216.0,28.1838,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
194,1030,2,1,,50104746,5281404,Inconclusive,30582681.0,216.0,31.6228,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
195,1033,2,2,,11537965,5281404,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
196,1332,1,1,,49698826,5281404,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
197,1379,1,2,,11111277,5281404,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
198,1379,1,2,,11113939,5281404,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
199,1379,1,2,,26747158,5281404,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
200,1379,1,2,,50104745,5281404,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
201,1379,1,2,,50104746,5281404,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
202,1422,1,1,,17405167,5281404,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
203,1422,1,1,,26612111,5281404,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
204,1452,1,1,,11111277,5281404,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
205,1452,1,1,,11113939,5281404,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
206,1454,1,1,,11111277,5281404,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
207,1454,1,1,,11113939,5281404,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
208,1454,1,1,,26747158,5281404,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
209,1454,1,1,,50104745,5281404,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
210,1454,1,1,,50104746,5281404,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
211,1457,1,1,,11111277,5281404,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
212,1457,1,1,,11113939,5281404,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
213,1457,1,1,,26747158,5281404,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
214,1457,1,1,,26752092,5281404,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
215,1457,1,1,,50104745,5281404,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
216,1457,1,1,,50104746,5281404,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
217,1458,1,1,,11111277,5281404,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
218,1458,1,1,,26747158,5281404,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
219,1458,1,1,,26752092,5281404,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
220,1458,1,1,,50104745,5281404,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
221,1459,1,1,,50104745,5281404,Inactive,27436948.0,4000.0,,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
222,1460,1,3,,11113939,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
223,1460,1,3,,26747158,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
224,1460,1,3,,26752092,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
225,1460,1,3,,50104745,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
226,1460,1,3,,50104746,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
227,1461,1,2,,50104745,5281404,Inconclusive,46395496.0,387129.0,5.0119,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
228,1463,1,1,,11113939,5281404,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
229,1463,1,1,,26747158,5281404,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
230,1463,1,1,,26752092,5281404,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
231,1463,1,1,,50104745,5281404,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
232,1463,1,1,,50104746,5281404,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
233,1467,1,3,,11111277,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
234,1467,1,3,,11113939,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
235,1467,1,3,,26747158,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
236,1467,1,3,,50104745,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
237,1467,1,3,,50104746,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
238,1468,1,1,,11113939,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
239,1468,1,1,,26747158,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
240,1468,1,1,,26752092,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
241,1468,1,1,,50104745,5281404,Inconclusive,92096784.0,4137.0,0.5623,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
242,1468,1,1,,50104746,5281404,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
243,1469,1,1,,11111277,5281404,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
244,1469,1,1,,11113939,5281404,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
245,1469,1,1,,26747158,5281404,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
246,1469,1,1,,26752092,5281404,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
247,1469,1,1,,50104745,5281404,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
248,1469,1,1,,50104746,5281404,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
249,1471,2,1,,11111276,5281404,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
250,1471,2,1,,11111277,5281404,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
251,1471,2,1,,11113939,5281404,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
252,1471,2,1,,26752092,5281404,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
253,1471,2,1,,50104746,5281404,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
254,1476,2,1,,11111277,5281404,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
255,1476,2,1,,11113939,5281404,Active,281307097.0,,25.1189,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
256,1476,2,1,,26747158,5281404,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
257,1476,2,1,,50104745,5281404,Inconclusive,281307097.0,,25.1189,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
258,1476,2,1,,50104746,5281404,Active,281307097.0,,39.8107,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
259,1477,1,1,,11111277,5281404,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
260,1477,1,1,,11113939,5281404,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
261,1477,1,1,,26752092,5281404,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
262,1477,1,1,,50104745,5281404,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
263,1477,1,1,,50104746,5281404,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
264,1478,2,1,,11111277,5281404,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
265,1478,2,1,,11113939,5281404,Inconclusive,281307097.0,,39.8107,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
266,1478,2,1,,26747158,5281404,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
267,1478,2,1,,50104745,5281404,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
268,1478,2,1,,50104746,5281404,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
269,1479,1,2,,11111277,5281404,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
270,1479,1,2,,11113939,5281404,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
271,1479,1,2,,26747158,5281404,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
272,1479,1,2,,26752092,5281404,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
273,1479,1,2,,50104745,5281404,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
274,1479,1,2,,50104746,5281404,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
275,1487,1,1,,11111277,5281404,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
276,1487,1,1,,26747158,5281404,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
277,1487,1,1,,50104745,5281404,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
278,1490,2,1,,11111277,5281404,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
279,1490,2,1,,11113939,5281404,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
280,1490,2,1,,26747158,5281404,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
281,1490,2,1,,26752092,5281404,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
282,1490,2,1,,49647165,5281404,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
283,1490,2,1,,50104746,5281404,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
284,1511,1,3,,49647165,5281404,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
285,1519,1,3,,11111277,5281404,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
286,1519,1,3,,11113939,5281404,Inconclusive,,,1.0,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
287,1519,1,3,,26747158,5281404,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
288,1519,1,3,,50104745,5281404,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
289,1519,1,3,,50104746,5281404,Inconclusive,,,3.1623,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
290,1527,1,3,,49647165,5281404,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
291,1529,1,1,,49647165,5281404,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
292,1530,1,1,,49647165,5281404,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
293,1531,1,1,,49647165,5281404,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
294,1549,1,2,,11537965,5281404,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
295,1552,1,3,,11537965,5281404,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
296,1554,1,1,,49647165,5281404,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
297,1556,1,4,,49647165,5281404,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
298,1565,2,2,,49647165,5281404,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
299,1566,2,3,,49647165,5281404,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
300,1578,3,2,,49647165,5281404,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
301,1621,1,2,,49647165,5281404,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
302,1637,1,2,,11537965,5281404,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
303,1648,1,2,,11537965,5281404,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
304,1654,2,2,,49647165,5281404,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
305,1656,2,2,,49647165,5281404,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
306,1662,1,2,,49647165,5281404,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
307,1663,1,2,,49647165,5281404,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
308,1672,1,3,,49647165,5281404,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
309,1700,1,2,,49647165,5281404,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
310,1705,1,2,,50104745,5281404,Inconclusive,6980812.0,,35.4813,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
311,1706,1,2,,49647165,5281404,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
312,1707,1,3,,50104745,5281404,Inactive,,,,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
313,1708,1,3,,50104745,5281404,Inactive,405898.0,,,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
314,1721,1,2,,49647165,5281404,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
315,1722,1,2,,49647165,5281404,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
316,1766,1,1,,11111277,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
317,1766,1,1,,11111277,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
318,1766,1,1,,11113939,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
319,1766,1,1,,11113939,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
320,1766,1,1,,26747158,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
321,1766,1,1,,26747158,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
322,1766,1,1,,49647165,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
323,1766,1,1,,49647165,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
324,1766,1,1,,50104745,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
325,1766,1,1,,50104745,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
326,1766,1,1,,50104746,5281404,Inactive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
327,1766,1,1,,50104746,5281404,Inactive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
328,1768,1,1,,11111277,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
329,1768,1,1,,11111277,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
330,1768,1,1,,11113939,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
331,1768,1,1,,11113939,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
332,1768,1,1,,26747158,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
333,1768,1,1,,26747158,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
334,1768,1,1,,49647165,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
335,1768,1,1,,49647165,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
336,1768,1,1,,50104745,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
337,1768,1,1,,50104745,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
338,1768,1,1,,50104746,5281404,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
339,1768,1,1,,50104746,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
340,1777,3,2,,49647165,5281404,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
341,1778,3,3,,49647165,5281404,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
342,1779,2,2,,49647165,5281404,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
343,1789,1,2,,49647165,5281404,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
344,1800,1,2,,49647165,5281404,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
345,1813,1,2,,49647165,5281404,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
346,1814,1,2,,49647165,5281404,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
347,1815,1,1,,50104745,5281404,Active,,,14.1254,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
348,1816,1,1,,50104745,5281404,Active,,,12.5893,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
349,1817,2,2,,49647165,5281404,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
350,1822,1,3,,49647165,5281404,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
351,1825,1,1,,49647165,5281404,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
352,1828,2,1,,50104745,5281404,Inconclusive,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
353,1832,2,1,,49647165,5281404,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
354,1845,1,2,,49647165,5281404,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
355,1850,2,1,,49647165,5281404,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
356,1851,1,2,,11111277,5281404,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
357,1851,1,2,,11113939,5281404,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
358,1851,1,2,1.0,11111277,5281404,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
359,1851,1,2,1.0,11113939,5281404,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
360,1851,1,2,2.0,11111277,5281404,Inconclusive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
361,1851,1,2,2.0,11113939,5281404,Active,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
362,1851,1,2,3.0,11111277,5281404,Inactive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
363,1851,1,2,3.0,11113939,5281404,Active,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
364,1851,1,2,4.0,11111277,5281404,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
365,1851,1,2,4.0,11113939,5281404,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
366,1851,1,2,5.0,11111277,5281404,Inactive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
367,1851,1,2,5.0,11113939,5281404,Inactive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
368,1861,2,1,,49647165,5281404,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
369,1863,2,1,,49647165,5281404,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
370,1865,1,1,,11111277,5281404,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
371,1865,1,1,,11113939,5281404,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
372,1865,1,1,,26747158,5281404,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
373,1865,1,1,,26752092,5281404,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
374,1865,1,1,,50104745,5281404,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
375,1865,1,1,,50104746,5281404,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
376,1868,1,4,,49647165,5281404,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
377,1875,2,1,,49647165,5281404,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
378,1876,1,1,,50104745,5281404,Inconclusive,,,11.2202,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
379,1877,1,1,,50104745,5281404,Inconclusive,,,15.8489,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
380,1882,1,1,,50104745,5281404,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
381,1883,1,1,,50104745,5281404,Active,,,10.0,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
382,1885,2,1,,49647165,5281404,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
383,1886,1,1,,50104745,5281404,Active,,,11.2202,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
384,1899,1,3,,49647165,5281404,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
385,1903,2,3,,49647165,5281404,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
386,1906,1,3,,49647165,5281404,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
387,1910,1,2,,49647165,5281404,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
388,1947,1,2,,49647165,5281404,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
389,1948,1,1,,11111277,5281404,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
390,1948,1,1,,11113939,5281404,Inactive,,,10.0,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
391,1948,1,1,,26747158,5281404,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
392,1948,1,1,,50104745,5281404,Inactive,,,12.5893,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
393,1948,1,1,,50104746,5281404,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
394,1950,1,3,,49647165,5281404,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
395,1961,2,2,,49647165,5281404,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
396,1962,1,2,,49647165,5281404,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
397,1967,1,1,,85231077,5281404,Inconclusive,4505907.0,5376.0,,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
398,1974,1,2,,49647165,5281404,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
399,1979,1,1,,49647165,5281404,Inactive,994798.0,,,,Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound,Screening,,
400,1984,1,3,,49647165,5281404,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
401,1986,1,2,,49647165,5281404,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
402,1987,1,2,,49647165,5281404,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
403,2006,3,2,,49647165,5281404,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
404,2006,3,2,,49647165,5281404,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
405,2006,3,2,,49647165,5281404,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
406,2012,3,2,,49647165,5281404,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
407,2013,2,2,,49647165,5281404,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
408,2014,3,2,,49647165,5281404,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
409,2016,1,3,,49647165,5281404,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
410,2023,1,3,,49647165,5281404,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
411,2025,1,3,,49647165,5281404,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
412,2029,1,3,,49647165,5281404,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
413,2052,2,1,,49647165,5281404,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
414,2057,1,2,,49647165,5281404,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
415,2058,3,2,,49647165,5281404,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
416,2066,1,4,,49647165,5281404,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
417,2071,2,2,,49647165,5281404,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
418,2073,2,3,,49647165,5281404,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
419,2073,2,3,,49647165,5281404,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
420,2094,1,2,,49647165,5281404,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
421,2094,1,2,,49647165,5281404,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
422,2094,1,2,,49647165,5281404,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
423,2097,1,2,,49647165,5281404,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
424,2098,1,1,,49647165,5281404,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
425,2099,1,1,,49647165,5281404,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
426,2100,1,1,,49647165,5281404,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
427,2101,1,1,,11111277,5281404,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
428,2101,1,1,,11113939,5281404,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
429,2101,1,1,,26747158,5281404,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
430,2101,1,1,,26752092,5281404,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
431,2101,1,1,,49647165,5281404,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
432,2101,1,1,,50104745,5281404,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
433,2101,1,1,,50104746,5281404,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
434,2107,1,1,,11111277,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
435,2107,1,1,,11113939,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
436,2107,1,1,,26747158,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
437,2107,1,1,,26752092,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
438,2107,1,1,,50104745,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
439,2107,1,1,,50104746,5281404,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
440,2112,1,1,,11111277,5281404,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
441,2112,1,1,,11113939,5281404,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
442,2112,1,1,,26747158,5281404,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
443,2112,1,1,,26752092,5281404,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
444,2112,1,1,,50104745,5281404,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
445,2112,1,1,,50104746,5281404,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
446,2129,1,2,,49647165,5281404,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
447,2130,1,3,,49647165,5281404,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
448,2147,1,1,,11111277,5281404,Inconclusive,221046486.0,,7.9433,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
449,2147,1,1,,11113939,5281404,Inconclusive,221046486.0,,31.6228,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
450,2147,1,1,,26747158,5281404,Inconclusive,221046486.0,,22.3872,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
451,2147,1,1,,50104745,5281404,Inconclusive,221046486.0,,28.1838,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
452,2147,1,1,,50104746,5281404,Inconclusive,221046486.0,,31.6228,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
453,2156,2,2,,49647165,5281404,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
454,2174,1,3,,49647165,5281404,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
455,2177,1,3,,49647165,5281404,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
456,2216,1,3,,49647165,5281404,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
457,2221,1,2,,49647165,5281404,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
458,2227,1,2,,49647165,5281404,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
459,2234,1,2,,49647165,5281404,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
460,2235,1,2,,49647165,5281404,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
461,2237,1,2,,49647165,5281404,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
462,2239,1,2,,49647165,5281404,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
463,2240,1,1,,85787864,5281404,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
464,2241,1,1,,85787864,5281404,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
465,2247,1,2,,49647165,5281404,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
466,2275,1,1,,85787864,5281404,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
467,2280,2,3,,49647165,5281404,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
468,2288,1,1,,49647165,5281404,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
469,2289,1,1,,49647165,5281404,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
470,2300,1,3,,49647165,5281404,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
471,2313,1,1,,85787864,5281404,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
472,2314,1,2,,49647165,5281404,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
473,2314,1,2,,49647165,5281404,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
474,2315,1,2,,49647165,5281404,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
475,2315,1,2,,49647165,5281404,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
476,2316,1,1,,85787864,5281404,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
477,2322,1,1,,85787864,5281404,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
478,2323,1,1,,50104745,5281404,Inactive,254220970.0,,39.8107,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
479,2326,1,1,,49647165,5281404,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
480,2326,1,1,,50104745,5281404,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
481,2330,1,1,,85787864,5281404,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
482,2353,1,3,,50104745,5281404,Inactive,282403581.0,,,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
483,2364,1,2,,50104745,5281404,Inactive,4557365.0,641.0,19.9526,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
484,2380,1,2,,49647165,5281404,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
485,2391,1,1,,49647165,5281404,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
486,2435,1,2,,49647165,5281404,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
487,2445,1,2,,49647165,5281404,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
488,2451,1,2,,11111277,5281404,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
489,2451,1,2,,11113939,5281404,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
490,2451,1,2,,26747158,5281404,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
491,2451,1,2,,49647165,5281404,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
492,2451,1,2,,50104745,5281404,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
493,2451,1,2,,50104746,5281404,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
494,2462,1,1,,49647165,5281404,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
495,2462,1,1,,49647165,5281404,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
496,2472,1,2,,11111277,5281404,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
497,2472,1,2,,11113939,5281404,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
498,2472,1,2,,26747158,5281404,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
499,2472,1,2,,49647165,5281404,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
500,2472,1,2,,50104746,5281404,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
501,2517,2,1,,11111277,5281404,Inconclusive,6980812.0,,7.0795,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
502,2517,2,1,,11113939,5281404,Inconclusive,6980812.0,,31.6228,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
503,2517,2,1,,26747158,5281404,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
504,2517,2,1,,26752092,5281404,Inconclusive,6980812.0,,39.8107,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
505,2517,2,1,,49647165,5281404,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
506,2517,2,1,,50104745,5281404,Inconclusive,6980812.0,,44.6684,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
507,2517,2,1,,50104746,5281404,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
508,2520,1,4,,49647165,5281404,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
509,2521,1,3,,49647165,5281404,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
510,2524,1,2,,49647165,5281404,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
511,2528,1,2,,11111277,5281404,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
512,2528,1,2,,11113939,5281404,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
513,2528,1,2,,26747158,5281404,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
514,2528,1,2,,49647165,5281404,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
515,2528,1,2,,50104745,5281404,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
516,2528,1,2,,50104746,5281404,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
517,2540,1,2,,49647165,5281404,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
518,2544,1,2,,49647165,5281404,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
519,2546,1,1,,11111277,5281404,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
520,2546,1,1,,11113939,5281404,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
521,2546,1,1,,26747158,5281404,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
522,2546,1,1,,49647165,5281404,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
523,2546,1,1,,50104746,5281404,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
524,2549,1,1,,11111277,5281404,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
525,2549,1,1,,11113939,5281404,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
526,2549,1,1,,26747158,5281404,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
527,2549,1,1,,26752092,5281404,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
528,2549,1,1,,50104745,5281404,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
529,2549,1,1,,50104746,5281404,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
530,2550,1,3,,49647165,5281404,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
531,2551,1,1,,11111277,5281404,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
532,2551,1,1,,11113939,5281404,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
533,2551,1,1,,26747158,5281404,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
534,2551,1,1,,49647165,5281404,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
535,2551,1,1,,50104746,5281404,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
536,2553,1,2,,49647165,5281404,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
537,2557,1,3,,49647165,5281404,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
538,2563,1,1,,49647165,5281404,Active,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
539,2599,1,2,,49647165,5281404,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
540,2606,1,2,,49647165,5281404,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
541,2629,1,1,,49647165,5281404,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
542,2642,1,2,,49647165,5281404,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
543,2648,1,2,,49647165,5281404,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
544,2650,2,1,,49647165,5281404,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
545,2660,1,1,,90341719,5281404,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
546,2661,1,1,,49647165,5281404,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
547,2662,2,1,,49647165,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
548,2662,2,1,,85231077,5281404,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
549,2666,1,1,,90341719,5281404,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
550,2667,1,1,,90341719,5281404,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
551,2668,1,1,,90341719,5281404,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
552,2675,1,1,,49647165,5281404,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
553,2675,1,1,,50104745,5281404,Unspecified,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
554,2676,1,2,,49647165,5281404,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
555,2685,1,1,,49647165,5281404,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
556,2690,1,2,,49647165,5281404,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
557,2716,1,1,,49647165,5281404,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
558,2717,1,2,,49647165,5281404,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
559,2718,1,1,,49647165,5281404,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
560,2732,1,1,,17405167,5281404,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
561,2751,2,2,,49647165,5281404,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
562,2765,1,2,,49647165,5281404,Inactive,20336315.0,10018.0,350.0,EC50_uM,Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis,Confirmatory,,
563,2765,1,2,,49647165,5281404,Inactive,167013344.0,,350.0,EC50_uM,Luminescence Cell-Based Dose Retest to Identify Inhibitors of A1 Apoptosis,Confirmatory,,
564,2774,1,3,,92303789,5281404,Inactive,,,,,LOPAC Circadian Assay,Screening,,
565,2796,1,4,,49647165,5281404,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
566,2797,1,2,,49647165,5281404,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
567,2805,2,2,,49647165,5281404,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
568,2806,2,2,,49647165,5281404,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
569,2825,1,2,,49647165,5281404,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
570,2964,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,Other,10612592.0,
571,8467,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against lung carcinoma (A549) cell line,Other,10612592.0,
572,40085,7,5,,103172786,5281404,Active,120758.0,289606.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
573,40085,7,5,,103172786,5281404,Active,120761.0,24947.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
574,40085,7,5,,103172786,5281404,Active,120763.0,140675.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
575,40085,7,5,,103172786,5281404,Active,120764.0,29707.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
576,40085,7,5,,103172786,5281404,Active,120769.0,25450.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
577,40085,7,5,,103172786,5281404,Active,120782.0,140674.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
578,40085,7,5,,103172786,5281404,Active,120788.0,29709.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
579,40085,7,5,,103172786,5281404,Active,120790.0,79211.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
580,40085,7,5,,103172786,5281404,Active,232127.0,29708.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
581,40085,7,5,,103172786,5281404,Active,544363.0,29689.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
582,40085,7,5,,103172786,5281404,Active,3023821.0,81658.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
583,40085,7,5,,103172786,5281404,Active,13959374.0,65191.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
584,40085,7,5,,103172786,5281404,Active,51317298.0,29705.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
585,40085,7,5,,103172786,5281404,Active,52000955.0,24922.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
586,40085,7,5,,103172786,5281404,Active,52000957.0,25451.0,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
587,40085,7,5,,103172786,5281404,Active,81902501.0,,12.388,IC50,Binding affinity for rat benzodiazepine receptor inverse agonist site,Confirmatory,8667357.0,
588,40509,7,2,,103172786,5281404,Active,,,12.388,IC50,Binding affinity towards benzodiazepine receptor inverse agonist site by the displacement of [3H]diazepam in rat cerebral cortical membranes.,Confirmatory,8411009.0,
589,40514,8,2,,103172786,5281404,Active,,,12.4,IC50,In vitro inhibition of 3[H]Diazepam binding to Benzodiazepine receptor from rat cerebral cortical membranes,Confirmatory,2167977.0,
590,40666,11,1,,103172786,5281404,Active,,,12.4,Ki,In vitro inhibition of [3H]diazepam binding to benzodiazepine receptor in rat cerebral cortical membrane,Confirmatory,6127411.0,
591,40988,8,2,,103172786,5281404,Active,,,12.3027,IC50,Inhibition on Benzodiazepine receptor,Confirmatory,9435905.0,
592,42569,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against renal cancer (CAKI-1) cell line,Other,10612592.0,
593,55535,3,8,,103172786,5281404,Unspecified,,,,,Percentage inhibition against cyclin dependent kinase 2 (CDK 2) at a concentration of 50 uM,Other,11909733.0,
594,55536,3,9,,103172786,5281404,Unspecified,,,,,Percentage inhibition against cyclin dependent kinase 5 (CDK 5) at a concentration of 50 uM,Other,11909733.0,
595,82702,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against embryonic lung fibroblast (HEL) cell line,Other,10612592.0,
596,94013,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-7d (pleotrophic resistance including MRP multidrug resistant protein),Other,10612592.0,
597,94188,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-CPT (pleotrophic mechanism including level of topoisomerase I),Other,10612592.0,
598,94194,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against drug resistant tumor cell line KB-VIN (expressing P-glycoprotein),Other,10612592.0,
599,95653,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against epidermoid carcinoma of the nasopharynx (KB) cell line,Other,10612592.0,
600,103712,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity against MCF-7 (human breast cancer) cell line.,Other,10612592.0,
601,125789,6,6,,103172786,5281404,Unspecified,84028191.0,1565.0,86.0,Ki,Inhibitory effect on Bufuralol 1'-hydroxylation by human liver microsomes (Ki = apparent inhibition constant),Confirmatory,8487254.0,
602,201791,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity was determined against melanoma cancer (SK-MEL-2) cell line,Other,10612592.0,
603,213899,5,1,,103172786,5281404,Unspecified,,,,,In vitro cytotoxic activity against U-87-MG (glioblastoma) cell line.,Other,10612592.0,
604,300391,6,1,,103172786,5281404,Unspecified,,,,,Effect on glucose-dependent insulin secretion activity per ug of total protein in rat RIN5F cells at 0.1 uM after 30 mins,Other,17583514.0,
605,300392,6,1,,103172786,5281404,Unspecified,,,,,Effect on glucose-dependent insulin secretion activity per ug of total protein in rat RIN5F cells at 1 uM after 30 mins,Other,17583514.0,
606,300393,6,1,,103172786,5281404,Unspecified,,,,,Effect on glucose-dependent insulin secretion activity per ug of total protein in rat RIN5F cells at 10 uM after 30 mins,Other,17583514.0,
607,300394,4,4,,103172786,5281404,Active,,,0.036000000000000004,Ki,Displacement of [3H]clonidine from I1-imidazoline binding site in bovine adrenal medulla plasma membrane,Confirmatory,17583514.0,
608,300395,4,4,,103172786,5281404,Active,,,0.054000000000000006,Ki,Displacement of [3H]idazoxan from I2-imidazoline binding site in rabbit kidney membrane,Confirmatory,17583514.0,
609,300396,4,4,,103172786,5281404,Unspecified,,,12.0,Ki,Displacement of [3H]clonidine from alpha-2-adrenoceptor in cerebral cortex of rat brain,Confirmatory,17583514.0,
610,338121,8,3,,103172786,5281404,Unspecified,,,,,Cytotoxicity against mouse P388 cells,Other,1791472.0,
611,338124,3,4,,103172786,5281404,Inactive,,,,,Antiviral activity against Herpes simplex virus (type 1 / strain F) ATCC VR 733 in african green monkey BSC1 cells assessed as excess radius from disk edge at 20 ug/disk,Other,1791472.0,
612,338132,3,4,,103172786,5281404,Inactive,,,,,Antiviral activity against Polio virus 1 Pfizer vaccine in african green monkey BSC1 cells assessed as excess radius from disk edge at 20 ug/disk,Other,1791472.0,
613,338141,3,5,,103172786,5281404,Inactive,,,,,Cytotoxicity against african green monkey BSC1 cells at 20 ug/disk,Other,1791472.0,
614,338146,4,3,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Escherichia coli assessed per disk,Other,1791472.0,
615,338147,4,3,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Bacillus subtilis assessed per disk,Other,1791472.0,
616,338148,4,3,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa assessed per disk,Other,1791472.0,
617,338149,4,3,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Candida albicans assessed per disk,Other,1791472.0,
618,338150,4,3,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Trichophyton mentagrophytes assessed per disk,Other,1791472.0,
619,338151,4,3,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Cladosporium resinae assessed per disk,Other,1791472.0,
620,343385,3,10,,103172786,5281404,Unspecified,136620.0,,,,Inhibition of Trypanosoma cruzi recombinant trypanothione reductase at 85 uM,Other,18558492.0,
621,348954,5,3,,103172786,5281404,Active,,,12.3027,IC50,Displacement of [3H]diazepam from GABAA/BzR in rat brain membrane,Confirmatory,17964693.0,
622,357032,6,2,,103172786,5281404,Unspecified,,,111.5,IC50,Cytotoxicity against human H9 cells,Confirmatory,11473435.0,
623,357033,9,1,,103172786,5281404,Active,,,10.7,EC50,Antiviral activity against HIV1 in human H9 cells assessed as inhibition of viral replication,Confirmatory,11473435.0,
624,357034,9,1,,103172786,5281404,Unspecified,,,,,"Therapeutic index, ratio of IC50 for human H9 cells to EC50 for HIV1",Other,11473435.0,
625,396084,5,2,,103172786,5281404,Active,,,12.3027,IC50,Displacement of [3H]diazepam from benzodiazepine receptor in rat brain,Confirmatory,18346822.0,
626,410367,6,2,,103172786,5281404,Unspecified,,,186.0,IC50,Cytotoxicity against human HeLa cells by MTT assay,Confirmatory,18952426.0,
627,410368,6,3,,103172786,5281404,Unspecified,,,151.0,IC50,Cytotoxicity against human Bel7402 cells by MTT assay,Confirmatory,18952426.0,
628,410369,6,3,,103172786,5281404,Unspecified,,,215.0,IC50,Cytotoxicity against human BGC823 cells by MTT assay,Confirmatory,18952426.0,
629,410370,6,2,,103172786,5281404,Unspecified,,,115.0,IC50,Cytotoxicity against human HepG2 cells by MTT assay,Confirmatory,18952426.0,
630,423203,8,2,,103172786,5281404,Unspecified,,,,,Cytotoxicity against mouse P388 cells,Other,19220033.0,
631,423204,5,1,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Bacillus subtilis measured per disk,Other,19220033.0,
632,423205,5,1,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Candida albicans measured per disk,Other,19220033.0,
633,423206,5,1,,103172786,5281404,Unspecified,,,,,Antimicrobial activity against Trichophyton mentagrophytes measured per disk,Other,19220033.0,
634,434955,1,2,,49647165,5281404,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
635,434959,1,1,,85787864,5281404,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
636,434962,1,2,,49647165,5281404,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
637,434973,1,3,,49647165,5281404,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
638,434989,1,1,,49647165,5281404,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
639,435003,1,3,,49647165,5281404,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
640,435005,1,1,,49647165,5281404,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
641,435022,2,2,,49647165,5281404,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
642,435030,1,2,,49647165,5281404,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
643,435030,1,2,,49647165,5281404,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
644,435123,3,10,,103172786,5281404,Unspecified,37537965.0,140609.0,,,Percentage NEK7 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
645,435176,3,10,,103172786,5281404,Unspecified,20139243.0,11040.0,,,Percentage PIM2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
646,435215,3,5,,103172786,5281404,Unspecified,,,,,Percentage AMPK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
647,435223,3,10,,103172786,5281404,Unspecified,729887.0,1445.0,,,Percentage CSK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
648,435225,3,10,,103172786,5281404,Unspecified,150421544.0,8444.0,,,Percentage DYRK3 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
649,435228,3,12,,103172786,5281404,Unspecified,232066.0,5595.0,,,Percentage ERK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
650,435233,3,11,,103172786,5281404,Unspecified,61213741.0,10114.0,,,Percentage HIPK3 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
651,435238,3,11,,103172786,5281404,Unspecified,2507195.0,5599.0,,,Percentage JNK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
652,435250,3,10,,103172786,5281404,Unspecified,37999482.0,9252.0,,,Percentage MSK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
653,435256,3,12,,103172786,5281404,Unspecified,2851522.0,6300.0,,,Percentage p38-gamma MAPK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
654,435260,3,11,,103172786,5281404,Unspecified,1730070.0,6197.0,,,Percentage RSK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
655,435300,3,10,,103172786,5281404,Unspecified,23396789.0,56924.0,,,Percentage PAK6 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
656,435315,3,11,,103172786,5281404,Unspecified,341941142.0,4140.0,,,Percentage MARK3 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
657,435317,3,10,,103172786,5281404,Unspecified,83305339.0,5292.0,,,Percentage PIM1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
658,435338,3,10,,103172786,5281404,Unspecified,3122301.0,8536.0,,,Percentage CaMK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
659,435339,3,11,,103172786,5281404,Unspecified,317373374.0,10645.0,,,Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
660,435350,3,11,,103172786,5281404,Unspecified,119554.0,5594.0,,,Percentage ERK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
661,435363,3,10,,103172786,5281404,Unspecified,50400857.0,9833.0,,,Percentage MELK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
662,435370,3,11,,103172786,5281404,Unspecified,134047835.0,5600.0,,,Percentage p38beta MAPK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
663,435373,3,10,,103172786,5281404,Unspecified,68067736.0,5590.0,,,Percentage PKCzeta activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
664,435374,3,10,,103172786,5281404,Unspecified,1709658.0,5347.0,,,Percentage PLK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
665,435375,3,11,,103172786,5281404,Unspecified,20178306.0,6195.0,,,Percentage RSK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
666,435378,3,10,,103172786,5281404,Unspecified,54041234.0,6198.0,,,Percentage S6K1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
667,435417,3,10,,103172786,5281404,Unspecified,12585288.0,10298.0,,,Percentage PAK4 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
668,435418,3,11,,103172786,5281404,Unspecified,12585290.0,57144.0,,,Percentage PAK5 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
669,435427,3,12,,103172786,5281404,Unspecified,60391226.0,207.0,,,Percentage PKBalpha activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
670,435454,3,10,,103172786,5281404,Unspecified,56404620.0,84254.0,,,Percentage CaMKKalpha activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
671,435461,3,11,,103172786,5281404,Unspecified,125266.0,1459.0,,,Percentage CK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
672,435461,3,11,,103172786,5281404,Unspecified,54037520.0,1460.0,,,Percentage CK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
673,435461,3,11,,103172786,5281404,Unspecified,55977123.0,1457.0,,,Percentage CK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
674,435493,3,11,,103172786,5281404,Unspecified,209572639.0,5587.0,,,Percentage PKD1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
675,435501,3,11,,103172786,5281404,Unspecified,300669714.0,4638.0,,,Percentage SmMLCK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
676,435539,3,5,,103172786,5281404,Unspecified,,,,,Percentage PHK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
677,435541,3,10,,103172786,5281404,Unspecified,125205.0,5566.0,,,Percentage PKA activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
678,435613,3,10,,103172786,5281404,Unspecified,30316115.0,8569.0,,,Percentage MNK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
679,435621,3,11,,103172786,5281404,Unspecified,2499600.0,1432.0,,,Percentage p38alpha MAPK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
680,435669,3,10,,103172786,5281404,Unspecified,17380162.0,5170.0,,,Percentage PDK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
681,435681,3,10,,103172786,5281404,Unspecified,1346538.0,9261.0,,,Percentage MAPKAPK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
682,435704,3,11,,103172786,5281404,Unspecified,317373473.0,9212.0,,,Percentage Aurora B activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
683,435706,3,11,,103172786,5281404,Unspecified,116241272.0,9024.0,,,Percentage BRSK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
684,435713,3,10,,103172786,5281404,Unspecified,317373343.0,1111.0,,,Percentage CHK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
685,435718,3,10,,103172786,5281404,Unspecified,254763289.0,29904.0,,,Percentage EF2K activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
686,435723,3,11,,103172786,5281404,Unspecified,20455502.0,2932.0,,,Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
687,435727,3,11,,103172786,5281404,Unspecified,85700366.0,5601.0,,,Percentage JNK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
688,435728,3,11,,103172786,5281404,Unspecified,2507196.0,5602.0,,,Percentage JNK3 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
689,435731,3,11,,103172786,5281404,Unspecified,90102033.0,2872.0,,,Percentage MNK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
690,435734,3,10,,103172786,5281404,Unspecified,37537993.0,10783.0,,,Percentage NEK6 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
691,435738,3,11,,103172786,5281404,Unspecified,6685642.0,5603.0,,,Percentage p38delta MAPK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
692,435747,3,10,,103172786,5281404,Unspecified,52000829.0,8550.0,,,Percentage PRAK activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
693,435756,3,10,,103172786,5281404,Unspecified,6175046.0,396442.0,,,Percentage Src activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
694,435814,3,10,,103172786,5281404,Unspecified,215274221.0,415116.0,,,Percentage PIM3 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
695,435819,3,11,,103172786,5281404,Unspecified,1170703.0,208.0,,,Percentage PKBbeta activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
696,435820,3,11,,103172786,5281404,Unspecified,317373571.0,5578.0,,,Percentage PKCalpha activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
697,435842,3,11,,103172786,5281404,Unspecified,27805738.0,6795.0,,,Percentage Aurora C activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
698,435847,3,10,,103172786,5281404,Unspecified,148887370.0,8445.0,,,Percentage DYRK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
699,435854,3,11,,103172786,5281404,Unspecified,14285497.0,3551.0,,,Percentage IKK-beta activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
700,435865,3,11,,103172786,5281404,Unspecified,400274.0,5604.0,,,Percentage MKK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
701,435867,3,11,,103172786,5281404,Unspecified,1709252.0,4751.0,,,Percentage NEK2a activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
702,435881,3,10,,103172786,5281404,Unspecified,269849761.0,9475.0,,,Percentage ROCK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
703,435883,3,10,,103172786,5281404,Unspecified,90185131.0,6446.0,,,Percentage SGK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
704,435962,3,11,,103172786,5281404,Unspecified,116051.0,1017.0,,,Percentage CDK2-cyclinA activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
705,435962,3,11,,103172786,5281404,Unspecified,8134359.0,8900.0,,,Percentage CDK2-cyclinA activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
706,435962,3,11,,103172786,5281404,Unspecified,311033358.0,890.0,,,Percentage CDK2-cyclinA activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
707,435979,3,11,,103172786,5281404,Unspecified,46577700.0,6788.0,,,Percentage MST2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
708,435987,3,11,,103172786,5281404,Unspecified,6225859.0,5586.0,,,Percentage PRK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
709,435995,3,10,,103172786,5281404,Unspecified,209572680.0,6732.0,,,Percentage SRPK1 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
710,436036,3,10,,103172786,5281404,Unspecified,78099784.0,16818.0,,,Percentage Lck activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
711,436037,3,10,,103172786,5281404,Unspecified,74762148.0,7867.0,,,Percentage MAPKAPK3 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
712,436071,3,11,,103172786,5281404,Unspecified,6685284.0,11200.0,,,Percentage CHK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
713,436072,3,11,,103172786,5281404,Unspecified,27923980.0,1453.0,,,Percentage CK1delta activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
714,436076,3,11,,103172786,5281404,Active,3219996.0,1859.0,,,Percentage DYRK1A activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
715,436083,3,11,,103172786,5281404,Unspecified,74760462.0,225689.0,,,Percentage ERK8 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
716,436086,3,10,,103172786,5281404,Unspecified,21431782.0,28996.0,,,Percentage HIPK2 activity remaining in the presence of 1uM inhibitor,Other,17850214.0,
717,449728,1,2,,49647165,5281404,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
718,449762,1,2,,49647165,5281404,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
719,449763,1,3,,49647165,5281404,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
720,453268,5,3,,103172786,5281404,Active,,,12.1,IC50,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6,Confirmatory,19781948.0,
721,453269,5,2,,103172786,5281404,Active,,,7.1,IC50,Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2,Confirmatory,19781948.0,
722,453270,5,2,,103172786,5281404,Unspecified,,,121.0,IC50,Cytotoxicity in human THP1 cells,Confirmatory,19781948.0,
723,463079,1,2,,49647165,5281404,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
724,463082,1,1,,49647165,5281404,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
725,463096,1,1,,50104745,5281404,Inactive,,,,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
726,463097,1,1,,50104745,5281404,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
727,463104,1,2,,49647165,5281404,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
728,463106,1,2,,90341719,5281404,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
729,463111,1,1,,49647165,5281404,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
730,463141,1,2,,49647165,5281404,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
731,463165,1,1,,49647165,5281404,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
732,463189,1,1,,53777711,5281404,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
733,463190,1,2,,49647165,5281404,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
734,463195,1,2,,49647165,5281404,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
735,463210,1,2,,49647165,5281404,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
736,463212,1,1,,49647165,5281404,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
737,463254,1,1,,49647165,5281404,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
738,473138,5,2,,103172786,5281404,Unspecified,,,130.0,IC50,Antiplatelet aggregation activity against collagen-induced platelet,Confirmatory,20329729.0,
739,485270,1,1,,49647165,5281404,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
740,485272,1,1,,49647165,5281404,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
741,485273,2,1,,49647165,5281404,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
742,485275,1,3,,49647165,5281404,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
743,485281,1,1,,11111277,5281404,Inactive,254220970.0,,11.2202,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
744,485281,1,1,,49647165,5281404,Inactive,254220970.0,,19.9526,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
745,485290,1,1,,11111277,5281404,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
746,485290,1,1,,11113939,5281404,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
747,485290,1,1,,26747158,5281404,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
748,485290,1,1,,26752092,5281404,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
749,485290,1,1,,50104745,5281404,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
750,485290,1,1,,50104746,5281404,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
751,485294,1,1,,49647165,5281404,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
752,485295,1,2,,90341719,5281404,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
753,485297,1,1,,49647165,5281404,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
754,485297,1,1,,90341719,5281404,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
755,485298,1,1,,49647165,5281404,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
756,485298,1,1,,90341719,5281404,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
757,485313,1,2,,49647165,5281404,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
758,485313,1,2,,90341719,5281404,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
759,485314,1,1,,49647165,5281404,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
760,485314,1,1,,50104745,5281404,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
761,485317,1,2,,49647165,5281404,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
762,485341,1,1,,49647165,5281404,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
763,485342,1,2,,90341719,5281404,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
764,485344,1,1,,49647165,5281404,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
765,485345,1,2,,90341719,5281404,Inconclusive,,,16.3601,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
766,485346,1,1,,49647165,5281404,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
767,485346,1,1,,49647165,5281404,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
768,485347,1,2,,49647165,5281404,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
769,485349,1,1,,49647165,5281404,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
770,485353,2,1,,49647165,5281404,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
771,485358,1,1,,49647165,5281404,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
772,485364,1,1,,49647165,5281404,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
773,485366,1,2,,90341719,5281404,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
774,485367,1,2,,49647165,5281404,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
775,485368,1,2,,90341719,5281404,Inconclusive,72386991.0,3656265.0,0.7569,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
776,488745,1,4,,85231077,5281404,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
777,488752,1,4,,85231077,5281404,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
778,488772,1,1,,90341719,5281404,Inactive,8659577.0,58819.0,21.1923,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
779,488773,1,2,,90341719,5281404,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
780,488788,1,1,,49647165,5281404,Inactive,6323930.0,855317.0,,AC50_uM,Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick,Confirmatory,,
781,488789,1,1,,49647165,5281404,Inactive,136429.0,,,AC50_uM,Trypsin Inhibition Assay Measured in Biochemical System Using Plate Reader - 2034-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
782,488815,1,1,,49647165,5281404,Inconclusive,1015837.0,,,AC50_uM,Ste24 Inhibition Assay Measured in Biochemical System Using Plate Reader - 2034-03_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
783,488816,1,1,,90341719,5281404,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
784,488837,1,1,,49647165,5281404,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
785,488837,1,1,,90341719,5281404,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
786,488839,1,1,,49647165,5281404,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
787,488839,1,1,,49647165,5281404,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
788,488847,1,3,,49647165,5281404,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
789,488862,1,1,,49647165,5281404,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
790,488890,1,2,,49647165,5281404,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
791,488895,1,2,,49647165,5281404,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
792,488896,1,1,,49647165,5281404,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
793,488899,1,1,,49647165,5281404,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
794,488922,1,2,,49647165,5281404,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
795,488949,1,2,,85231077,5281404,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
796,488949,1,2,,90341719,5281404,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
797,488953,1,1,,90341719,5281404,Inactive,187960037.0,10951.0,,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
798,488965,1,2,,49647165,5281404,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
799,488966,1,1,,49647165,5281404,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
800,488975,1,2,,49647165,5281404,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
801,488977,1,2,,49647165,5281404,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
802,488978,1,1,,90341719,5281404,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
803,488979,1,1,,50104745,5281404,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
804,488980,1,1,,85231077,5281404,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
805,488981,1,1,,90341719,5281404,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
806,488982,1,1,,90341719,5281404,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
807,488983,1,1,,90341719,5281404,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
808,489030,2,1,,49647165,5281404,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
809,489031,2,1,,49647165,5281404,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
810,492947,1,1,,49647165,5281404,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
811,492953,1,1,,49647165,5281404,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
812,492956,1,1,,49647165,5281404,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
813,492972,1,1,,49647165,5281404,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
814,493005,1,1,,49647165,5281404,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
815,493008,1,1,,49647165,5281404,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
816,493008,1,1,,49647165,5281404,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
817,493008,1,1,,49647165,5281404,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
818,493008,1,1,,49647165,5281404,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
819,493011,1,1,,49647165,5281404,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
820,493012,1,1,,49647165,5281404,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
821,493014,1,1,,49647165,5281404,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
822,493036,1,2,,49647165,5281404,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
823,493056,1,1,,49647165,5281404,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
824,493084,1,1,,49647165,5281404,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
825,493087,1,1,,49647165,5281404,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
826,493091,1,1,,49647165,5281404,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
827,493098,1,1,,49647165,5281404,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
828,493106,1,1,,90341719,5281404,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
829,493107,1,1,,90341719,5281404,Active,116283940.0,79915.0,9.1962,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
830,493127,1,1,,50104745,5281404,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
831,493131,1,1,,49647165,5281404,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
832,493153,1,1,,90341719,5281404,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
833,493153,1,1,,90341719,5281404,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
834,493160,1,1,,49647165,5281404,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
835,493164,1,2,,90341719,5281404,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
836,493164,1,2,,90341719,5281404,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
837,493164,1,2,,90341719,5281404,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
838,493187,1,2,,49647165,5281404,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
839,493189,1,1,,50104745,5281404,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
840,493244,1,1,,49647165,5281404,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
841,493244,1,1,,49647165,5281404,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
842,493244,1,1,,49647165,5281404,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
843,493244,1,1,,49647165,5281404,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
844,504326,1,2,,49647165,5281404,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
845,504326,1,2,,49647165,5281404,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
846,504327,1,1,,11111277,5281404,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
847,504327,1,1,,49647165,5281404,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
848,504327,1,1,,90341719,5281404,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
849,504329,1,1,,49647165,5281404,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
850,504332,1,1,,11111277,5281404,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
851,504332,1,1,,49647165,5281404,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
852,504332,1,1,,50104745,5281404,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
853,504332,1,1,,90341719,5281404,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
854,504333,1,1,,49647165,5281404,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
855,504339,1,1,,49647165,5281404,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
856,504357,1,1,,49647165,5281404,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
857,504357,1,1,,49647165,5281404,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
858,504364,1,1,,85231077,5281404,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
859,504406,1,1,,49647165,5281404,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
860,504408,2,1,,49647165,5281404,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
861,504411,1,1,,49647165,5281404,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
862,504414,1,1,,49647165,5281404,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
863,504414,1,1,,49647165,5281404,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
864,504423,1,1,,49647165,5281404,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
865,504441,1,1,,49647165,5281404,Active,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
866,504444,1,1,,49647165,5281404,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
867,504454,1,3,,49647165,5281404,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
868,504462,1,1,,49647165,5281404,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
869,504466,1,1,,49647165,5281404,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
870,504467,1,1,,49647165,5281404,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
871,504490,1,2,,49647165,5281404,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
872,504523,1,1,,49647165,5281404,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
873,504523,1,1,,49647165,5281404,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
874,504536,1,1,,90341719,5281404,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
875,504547,1,1,,90341719,5281404,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
876,504548,1,2,,90341719,5281404,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
877,504558,1,1,,49647165,5281404,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
878,504577,2,2,,49647165,5281404,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
879,504582,2,1,,49647165,5281404,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
880,504621,1,1,,49647165,5281404,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
881,504634,1,1,,49647165,5281404,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
882,504648,1,1,,49647165,5281404,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
883,504651,1,1,,49647165,5281404,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
884,504652,1,1,,49647165,5281404,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
885,504660,1,1,,49647165,5281404,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
886,504690,1,3,,49647165,5281404,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
887,504692,2,2,,49647165,5281404,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
888,504700,1,1,,49647165,5281404,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
889,504700,1,1,,49647165,5281404,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
890,504706,1,1,,49647165,5281404,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
891,504707,1,1,,49647165,5281404,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
892,504707,1,1,,49647165,5281404,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
893,504720,1,1,,49647165,5281404,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
894,504734,1,1,,49647165,5281404,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
895,504766,2,1,,49647165,5281404,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
896,504775,1,1,,49647165,5281404,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
897,504803,1,1,,49647165,5281404,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
898,504810,1,2,,49647165,5281404,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
899,504810,1,2,,90341719,5281404,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
900,504812,1,2,,49647165,5281404,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
901,504812,1,2,,90341719,5281404,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
902,504821,1,1,,85231077,5281404,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
903,504832,1,1,,49647165,5281404,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
904,504834,1,1,,49647165,5281404,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
905,504836,1,2,,90341719,5281404,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
906,504842,1,1,,49647165,5281404,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
907,504845,1,1,,49647165,5281404,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
908,504845,1,1,,90341719,5281404,Inactive,86301163.0,5999.0,15.003,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
909,504847,1,1,,11111277,5281404,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
910,504847,1,1,,49647165,5281404,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
911,504847,1,1,,90341719,5281404,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
912,504865,1,1,,11111277,5281404,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
913,504865,1,1,,90341719,5281404,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
914,504884,1,2,,49647165,5281404,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
915,504891,1,1,,49647165,5281404,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
916,504894,1,1,,49647165,5281404,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
917,504937,1,2,,49647165,5281404,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
918,521220,3,3,,103172786,5281404,Inactive,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
919,524790,7,2,,103172786,5281404,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
920,524791,7,2,,103172786,5281404,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
921,524792,7,2,,103172786,5281404,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
922,524794,7,1,,103172786,5281404,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
923,524795,7,2,,103172786,5281404,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
924,524796,7,1,,103172786,5281404,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
925,540253,1,1,,49647165,5281404,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
926,540253,1,1,,49647165,5281404,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
927,540253,1,1,,49647165,5281404,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
928,540256,1,2,,49647165,5281404,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
929,540256,1,2,,50104745,5281404,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
930,540256,1,2,,90341719,5281404,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
931,540263,1,1,,49647165,5281404,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
932,540263,1,1,,49647165,5281404,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
933,540267,1,1,,49647165,5281404,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
934,540275,1,1,,49647165,5281404,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
935,540276,1,2,,11111276,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
936,540276,1,2,,11111277,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
937,540276,1,2,,11113939,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
938,540276,1,2,,26747158,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
939,540276,1,2,,26752092,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
940,540276,1,2,,49647165,5281404,Inconclusive,420597.0,,19.9526,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
941,540276,1,2,,50104745,5281404,Inconclusive,420597.0,,2.8184,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
942,540276,1,2,,50104746,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
943,540276,1,2,,50104747,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
944,540276,1,2,,85231077,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
945,540276,1,2,,90341719,5281404,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
946,540277,1,1,,49647165,5281404,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
947,540295,1,1,,49647165,5281404,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
948,540303,1,1,,49647165,5281404,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
949,540303,1,1,,49647165,5281404,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
950,540303,1,1,,49647165,5281404,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
951,540308,1,1,,49647165,5281404,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
952,540317,1,1,,49647165,5281404,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
953,540336,1,1,,49647165,5281404,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
954,540336,1,1,,49647165,5281404,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
955,540364,1,2,,49647165,5281404,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
956,558029,4,2,,103172786,5281404,Active,,,,IC50,Antiviral activity against JC polyomavirus M1/SVEdelta infected in human SVG-A cells assessed as inhibition of viral replication after 3 days,Confirmatory,19258267.0,
957,558036,1,3,,103172786,5281404,Unspecified,,,,,"Therapeutic index, ratio of TC50 for JC polyomavirus M1/SVEdelta infected human SVG-A cells to EC50 for JC polyomavirus M1/SVEdelta",Other,19258267.0,
958,558037,3,2,,103172786,5281404,Unspecified,,,40.0,TC50,Cytotoxicity against human SVG-A cells,Confirmatory,19258267.0,
959,588334,1,1,,49647165,5281404,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
960,588335,1,1,,49647165,5281404,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
961,588342,1,1,,49647165,5281404,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
962,588345,1,1,,49647165,5281404,Inactive,6978787.0,25255.0,,AC50_uM,MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
963,588348,1,1,,49647165,5281404,Inactive,,,,AC50_uM,MLPCN Dyrk1A Artifact Assay Measured in Biochemical System Using Plate Reader - 2124-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
964,588349,1,1,,90341719,5281404,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
965,588352,1,2,,49647165,5281404,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
966,588354,1,1,,49647165,5281404,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
967,588358,1,2,,49647165,5281404,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
968,588378,1,1,,90341719,5281404,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
969,588379,1,2,,124880330,5281404,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
970,588379,1,2,,124880332,5281404,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
971,588391,1,1,,49647165,5281404,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
972,588405,1,1,,49647165,5281404,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
973,588413,1,2,,49647165,5281404,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
974,588436,1,1,,49647165,5281404,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
975,588453,1,1,,49647165,5281404,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
976,588453,1,1,,85231077,5281404,Inactive,8659577.0,58819.0,56.2341,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
977,588453,1,1,,90341719,5281404,Inactive,8659577.0,58819.0,22.3872,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
978,588453,1,1,,124880330,5281404,Inactive,8659577.0,58819.0,100.0,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
979,588456,1,1,,49647165,5281404,Inactive,8659577.0,58819.0,19.9526,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
980,588456,1,1,,90341719,5281404,Inactive,8659577.0,58819.0,28.1838,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
981,588456,1,1,,124880330,5281404,Inactive,8659577.0,58819.0,79.4328,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
982,588458,1,1,,49647165,5281404,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
983,588473,1,1,,49647165,5281404,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
984,588473,1,1,,49647165,5281404,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
985,588475,1,2,,49647165,5281404,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
986,588475,1,2,,49647165,5281404,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
987,588478,1,2,,125167552,5281404,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
988,588489,1,1,,49647165,5281404,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
989,588492,1,1,,49647165,5281404,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
990,588493,1,2,,49647165,5281404,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
991,588497,1,2,,49647165,5281404,Inconclusive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
992,588497,1,2,,49647165,5281404,Inconclusive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
993,588497,1,2,,49647165,5281404,Inconclusive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
994,588499,1,3,,49647165,5281404,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
995,588499,1,3,,49647165,5281404,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
996,588499,1,3,,49647165,5281404,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
997,588501,1,2,,49647165,5281404,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
998,588501,1,2,,49647165,5281404,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
999,588501,1,2,,49647165,5281404,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
1000,588511,1,2,,49647165,5281404,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
1001,588549,1,1,,49647165,5281404,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1002,588579,1,1,,11111277,5281404,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1003,588579,1,1,,49647165,5281404,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1004,588579,1,1,,90341719,5281404,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1005,588579,1,1,,124880330,5281404,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1006,588579,1,1,,124880331,5281404,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1007,588579,1,1,,124880332,5281404,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1008,588579,1,1,,124880334,5281404,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1009,588590,1,1,,49647165,5281404,Inactive,154350220.0,11201.0,100.0,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1010,588590,1,1,,50104745,5281404,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1011,588590,1,1,,124880330,5281404,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1012,588591,1,1,,49647165,5281404,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1013,588591,1,1,,50104745,5281404,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1014,588621,1,1,,49647165,5281404,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
1015,588627,1,1,,49647165,5281404,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
1016,588664,1,2,,49647165,5281404,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1017,588664,1,2,,49647165,5281404,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1018,588674,1,2,,49647165,5281404,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1019,588675,1,1,,49647165,5281404,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
1020,588676,1,1,,49647165,5281404,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
1021,588689,1,1,,49647165,5281404,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
1022,588692,2,1,,49647165,5281404,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1023,588726,1,2,,49647165,5281404,Active,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
1024,588727,1,1,,49647165,5281404,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
1025,588795,1,1,,49647165,5281404,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1026,588795,1,1,,90341719,5281404,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1027,588795,1,1,,124880330,5281404,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1028,588814,1,3,,49647165,5281404,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
1029,588819,1,4,,49647165,5281404,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
1030,588834,2,1,,50104745,5281404,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1031,588849,1,1,,49647165,5281404,Inactive,73858575.0,9986.0,,AC50_uM,Human Ras-Converting Enzyme Inhibition Assay Measured in Biochemical System Using Plate Reader - 2034-04_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1032,588850,1,1,,49647165,5281404,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
1033,588852,1,3,,49647165,5281404,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
1034,588855,1,1,,49647165,5281404,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1035,588855,1,1,,124880330,5281404,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1036,588856,1,1,,49647165,5281404,Inactive,,,2.2387,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1037,588856,1,1,,124880330,5281404,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1038,602123,1,1,,49647165,5281404,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
1039,602141,1,1,,49647165,5281404,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
1040,602162,1,1,,49647165,5281404,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
1041,602163,1,1,,49647165,5281404,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
1042,602179,1,2,,49647165,5281404,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
1043,602229,1,1,,49647165,5281404,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
1044,602233,1,1,,49647165,5281404,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1045,602244,1,2,,49647165,5281404,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
1046,602247,1,2,,49647165,5281404,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1047,602248,1,2,,49647165,5281404,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1048,602250,1,2,,49647165,5281404,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
1049,602252,1,1,,49647165,5281404,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1050,602252,1,1,,49647165,5281404,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1051,602261,1,1,,49647165,5281404,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
1052,602274,1,2,,49647165,5281404,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
1053,602281,1,1,,49647165,5281404,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1054,602281,1,1,,49647165,5281404,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1055,602310,1,2,,49647165,5281404,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1056,602310,1,2,,124880330,5281404,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1057,602313,1,1,,49647165,5281404,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
1058,602329,1,1,,49647165,5281404,Inconclusive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1059,602332,1,1,,11111277,5281404,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1060,602332,1,1,,49647165,5281404,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1061,602332,1,1,,90341719,5281404,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1062,602332,1,1,,124880330,5281404,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1063,602332,1,1,,124880331,5281404,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1064,602332,1,1,,124880332,5281404,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1065,602332,1,1,,124880334,5281404,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1066,602340,1,2,,49647165,5281404,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
1067,602346,1,1,,49647165,5281404,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1068,602363,1,1,,49647165,5281404,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
1069,602393,1,1,,49647165,5281404,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1070,602396,1,2,,49647165,5281404,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1071,602399,1,2,,49647165,5281404,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
1072,602405,1,1,,49647165,5281404,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1073,602410,1,1,,49647165,5281404,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
1074,602429,1,1,,49647165,5281404,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
1075,602438,1,1,,49647165,5281404,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
1076,602440,1,1,,49647165,5281404,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
1077,602449,1,2,,49647165,5281404,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
1078,602481,1,1,,49647165,5281404,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1079,623870,1,1,,49647165,5281404,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1080,623870,1,1,,49647165,5281404,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1081,623877,1,1,,49647165,5281404,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
1082,624037,1,3,,49647165,5281404,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1083,624038,1,3,,49647165,5281404,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1084,624040,1,3,,49647165,5281404,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1085,624101,1,2,,85787864,5281404,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1086,624125,1,4,,49647165,5281404,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1087,624126,1,3,,49647165,5281404,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1088,624127,1,2,,49647165,5281404,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1089,624146,1,1,,90341719,5281404,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
1090,624147,1,1,,90341719,5281404,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
1091,624148,1,2,,90341719,5281404,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
1092,624149,1,1,,90341719,5281404,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
1093,624156,1,1,,85787864,5281404,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
1094,624168,1,1,,49647165,5281404,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
1095,624169,1,1,,49647165,5281404,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
1096,624170,1,1,,49647165,5281404,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1097,624171,1,1,,49647165,5281404,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
1098,624172,1,1,,49647165,5281404,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1099,624173,1,3,,49647165,5281404,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1100,624178,1,1,,49647165,5281404,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1101,624178,1,1,,124880330,5281404,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1102,624202,1,1,,49647165,5281404,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1103,624202,1,1,,124880330,5281404,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1104,624204,1,2,,49647165,5281404,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
1105,624246,1,1,,49647165,5281404,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
1106,624256,1,2,,49647165,5281404,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
1107,624263,1,1,,49647165,5281404,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1108,624263,1,1,,49647165,5281404,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1109,624263,1,1,,124880330,5281404,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1110,624263,1,1,,124880330,5281404,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1111,624263,1,1,,124880331,5281404,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1112,624263,1,1,,124880331,5281404,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1113,624267,1,2,,49647165,5281404,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1114,624267,1,2,,49647165,5281404,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1115,624268,1,3,,49647165,5281404,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
1116,624287,1,1,,49647165,5281404,Inactive,52000961.0,2778.0,,Potency,"qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1117,624288,1,1,,49647165,5281404,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1118,624291,1,1,,49647165,5281404,Inactive,121312.0,1081.0,,Potency,qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy,Confirmatory,,
1119,624296,1,1,,49647165,5281404,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1120,624297,1,1,,49647165,5281404,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1121,624304,1,2,,49647165,5281404,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
1122,624330,1,2,,49647165,5281404,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
1123,624352,1,1,,49647165,5281404,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
1124,624354,1,1,,49647165,5281404,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
1125,624377,1,1,,49647165,5281404,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
1126,624414,1,1,,49647165,5281404,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1127,624414,1,1,,124880330,5281404,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1128,624415,1,2,,49647165,5281404,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1129,624416,1,1,,49647165,5281404,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
1130,624417,1,1,,49647165,5281404,Inconclusive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
1131,624418,1,1,,49647165,5281404,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
1132,624455,1,1,,90341719,5281404,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
1133,624463,1,1,,49647165,5281404,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
1134,624464,1,1,,49647165,5281404,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
1135,624465,1,1,,49647165,5281404,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
1136,624466,1,3,,49647165,5281404,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1137,624467,1,1,,49647165,5281404,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1138,624483,1,1,,49647165,5281404,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1139,625776,3,2,,103172786,5281404,Unspecified,,,130.0,IC50,Antiplatelet activity in rabbit platelets assessed as inhibition of collagen-induced platelet aggregation,Confirmatory,21983333.0,
1140,651550,1,1,,49647165,5281404,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
1141,651560,1,1,,49647165,5281404,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1142,651572,1,2,,49647165,5281404,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
1143,651602,1,1,,49647165,5281404,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1144,651602,1,1,,49647165,5281404,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1145,651602,1,1,,49647165,5281404,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1146,651610,2,1,,49647165,5281404,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1147,651616,1,1,,49647165,5281404,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
1148,651635,1,3,,11111277,5281404,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1149,651635,1,3,,49647165,5281404,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1150,651635,1,3,,90341719,5281404,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1151,651636,1,1,,49647165,5281404,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1152,651640,1,1,,49647165,5281404,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
1153,651644,1,1,,49647165,5281404,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1154,651647,1,1,,49647165,5281404,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1155,651654,1,1,,49647165,5281404,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1156,651657,1,1,,49647165,5281404,Active,216548193.0,8438.0,58.37,AC50_uM,Identification of Inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1157,651658,1,1,,49647165,5281404,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1158,651661,2,1,,49647165,5281404,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1159,651673,1,1,,49647165,5281404,Inactive,,,,AC50_uM,Identification of Rad54 Inhibitors - Ruling Out Compounds That Bind DNA Measured in Biochemical System Using Plate Reader - 2159-04_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1160,651692,1,1,,49647165,5281404,Inactive,,,,AC50_uM,Cytotoxicity assay Measured in Cell-Based System Using Plate Reader - 2159-05_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1161,651699,1,1,,49647165,5281404,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1162,651699,1,1,,49647165,5281404,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1163,651702,1,2,,49647165,5281404,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1164,651704,2,1,,49647165,5281404,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1165,651710,1,1,,49647165,5281404,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1166,651711,2,1,,49647165,5281404,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1167,651718,1,2,,49647165,5281404,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
1168,651719,1,2,,49647165,5281404,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
1169,651724,1,1,,49647165,5281404,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1170,651725,1,1,,49647165,5281404,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1171,651768,1,2,,49647165,5281404,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
1172,651800,1,1,,49647165,5281404,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
1173,651819,1,1,,49647165,5281404,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1174,651820,1,1,,49647165,5281404,Inconclusive,,,31.6228,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1175,651821,2,4,,49647165,5281404,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
1176,651828,1,2,,121361316,5281404,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
1177,651957,1,1,,49647165,5281404,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
1178,651958,1,1,,49647165,5281404,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1179,651965,1,1,,49647165,5281404,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1180,651965,1,1,,124880330,5281404,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1181,651999,1,1,,49647165,5281404,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1182,652010,1,1,,49647165,5281404,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1183,652017,1,1,,49647165,5281404,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
1184,652025,1,1,,49647165,5281404,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1185,652039,1,1,,49647165,5281404,Active,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1186,652048,1,2,,49647165,5281404,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1187,652051,1,1,,49647165,5281404,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1188,652054,1,1,,49647165,5281404,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1189,652067,1,4,,49647165,5281404,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
1190,652104,1,1,,49647165,5281404,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1191,652105,1,1,,49647165,5281404,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1192,652106,1,1,,49647165,5281404,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1193,652106,1,1,,90341719,5281404,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1194,652106,1,1,,124880330,5281404,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1195,652115,1,1,,49647165,5281404,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
1196,652126,1,3,,49647165,5281404,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
1197,652141,1,1,,49647165,5281404,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts,Screening,,
1198,652154,1,1,,49647165,5281404,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1199,652162,2,1,,49647165,5281404,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1200,652163,1,1,,49647165,5281404,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1201,652197,1,1,,49647165,5281404,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1202,652257,1,1,,49647165,5281404,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1203,656680,5,5,,103172786,5281404,Active,14916521.0,,20.91,IC50,Inhibition of electric eel AChE using acetylcholine iodide as substrate measured every 5 sec for 2 mins by Ellman's method,Confirmatory,22425563.0,
1204,656681,1,8,,103172786,5281404,Unspecified,14916521.0,,,,Inhibition of electric eel AChE using acetylcholine iodide as substrate at 10'-4 M measured every 5 sec for 2 mins by Ellman's method,Other,22425563.0,
1205,656684,5,5,,103172786,5281404,Inconclusive,113037.0,43.0,,IC50,Inhibition of human AChE by Ellman's method,Confirmatory,22425563.0,
1206,656685,1,8,,103172786,5281404,Unspecified,113037.0,43.0,,,Inhibition of human AChE at 10'-4 M by Ellman's method,Other,22425563.0,
1207,686940,1,1,,49647165,5281404,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
1208,686949,1,1,,49647165,5281404,Active,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1209,686952,1,2,,49647165,5281404,Active,,,,,Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence,Screening,,
1210,686964,1,1,,49647165,5281404,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1211,686970,1,2,,49647165,5281404,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1212,686971,1,2,,49647165,5281404,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1213,686977,2,1,,49698826,5281404,Inconclusive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
1214,686978,1,1,,49647165,5281404,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1215,686978,1,1,,124880330,5281404,Active,79154014.0,55775.0,23.715,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1216,686978,1,1,,124880331,5281404,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1217,686978,1,1,,124880332,5281404,Inconclusive,79154014.0,55775.0,26.6086,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1218,686978,1,1,,124880334,5281404,Inconclusive,79154014.0,55775.0,20.5962,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1219,686979,1,1,,49647165,5281404,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1220,686979,1,1,,124880330,5281404,Inconclusive,79154014.0,55775.0,14.9631,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1221,686979,1,1,,124880331,5281404,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1222,686979,1,1,,124880332,5281404,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1223,686979,1,1,,124880334,5281404,Inconclusive,79154014.0,55775.0,25.929000000000002,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1224,686992,2,1,,49647165,5281404,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
1225,686996,1,1,,49647165,5281404,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1226,687014,1,1,,49647165,5281404,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1227,687016,1,1,,49647165,5281404,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1228,687035,1,1,,163564559,5281404,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
1229,687037,1,3,,163564559,5281404,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
1230,720504,1,1,,49647165,5281404,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1231,720508,1,1,,49647165,5281404,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1232,720509,1,1,,49647165,5281404,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1233,720511,1,1,,49647165,5281404,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
1234,720532,1,1,,11111277,5281404,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1235,720532,1,1,,124880330,5281404,Inconclusive,420597.0,,15.8489,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1236,720532,1,1,,124880331,5281404,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1237,720532,1,1,,124880332,5281404,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1238,720532,1,1,,124880334,5281404,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1239,720533,1,1,,11111277,5281404,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1240,720533,1,1,,124880330,5281404,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1241,720533,1,1,,124880331,5281404,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1242,720533,1,1,,124880332,5281404,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1243,720533,1,1,,124880334,5281404,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1244,720538,1,2,,90341719,5281404,Inactive,220983390.0,410.0,,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
1245,720542,1,2,,49647165,5281404,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1246,720543,1,1,,49647165,5281404,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1247,720551,1,2,,49647165,5281404,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1248,720553,1,2,,49647165,5281404,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1249,720559,1,2,,90341719,5281404,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
1250,720572,1,2,,90341719,5281404,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
1251,720573,1,2,,90341719,5281404,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
1252,720579,2,1,,49647165,5281404,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1253,720579,2,1,,124880330,5281404,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1254,720579,2,1,,124880331,5281404,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1255,720579,2,1,,124880334,5281404,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1256,720580,1,1,,49647165,5281404,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1257,720580,1,1,,124880330,5281404,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1258,720580,1,1,,124880331,5281404,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1259,720580,1,1,,124880334,5281404,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1260,720582,1,1,,49647165,5281404,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
1261,720596,1,1,,49647165,5281404,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
1262,720647,1,2,,49647165,5281404,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
1263,720648,1,1,,49647165,5281404,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
1264,720700,1,4,,49647165,5281404,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
1265,720702,1,1,,49647165,5281404,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1266,720704,1,4,,49647165,5281404,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
1267,720706,1,2,,49647165,5281404,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1268,720707,1,2,,49647165,5281404,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1269,720708,1,2,,49647165,5281404,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1270,720709,1,2,,49647165,5281404,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1271,720711,1,2,,49647165,5281404,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1272,743126,1,1,,49647165,5281404,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1273,743205,1,1,,90341719,5281404,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1274,743205,1,1,,90341719,5281404,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1275,743206,1,1,,90341719,5281404,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1276,743206,1,1,,90341719,5281404,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1277,743207,1,1,,90341719,5281404,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1278,743207,1,1,,90341719,5281404,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1279,743238,1,1,,49647165,5281404,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
1280,743244,1,1,,90341719,5281404,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1281,743247,1,2,,49647165,5281404,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1282,743255,1,1,,49647165,5281404,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1283,743266,1,2,,49647165,5281404,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1284,743269,1,1,,49647165,5281404,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1285,743269,1,1,,49647165,5281404,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1286,743279,1,2,,49647165,5281404,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1287,743287,1,1,,49647165,5281404,Inactive,,,,,Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity,Screening,,
1288,743397,1,1,,49647165,5281404,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1289,743398,1,1,,49647165,5281404,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1290,743445,1,1,,49647165,5281404,Inactive,109633019.0,7468.0,,,"Development of Small Molecule Probes of the Histone Methyltransferase, NSD2 Measured in Biochemical System Using Plate Reader - 7053-01_Inhibitor_SinglePoint_HTS_Activity_Set2",Screening,,
1291,977599,1,1,,103172786,5281404,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1292,977602,1,2,,103172786,5281404,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1293,1053175,2,1,,125167552,5281404,Inactive,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
1294,1053197,1,1,,49647165,5281404,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1295,1094436,1,2,,103172786,5281404,Active,,,12.3027,IC50,Binding affinity to GABA-A receptor benzodiazepine site (unknown origin),Confirmatory,,
1296,1117267,1,1,,49647165,5281404,Inactive,48145933.0,7276.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of Transthyretin (TTR) transcription,Screening,,
1297,1159524,1,1,,49647165,5281404,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1298,1159524,1,1,,124880330,5281404,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1299,1159524,1,1,,124880331,5281404,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1300,1159524,1,1,,124880334,5281404,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1301,1159550,3,1,,252401802,5281404,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
1302,1159580,2,1,,268735786,5281404,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1303,1159580,2,1,,273002841,5281404,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1304,1159583,2,1,,125167552,5281404,Inactive,,,,,High throughput screen for small molecule inhibitors of a hypoxia-regulated fluorescent biosensor in Mycobacterium tuberculosis,Other,,
1305,1159606,1,1,,49647165,5281404,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1306,1159607,2,1,,312596067,5281404,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1307,1181716,1,1,,103172786,5281404,Active,,,0.27,IC50,Antimicrobial activity against amastigote stage of Leishmania infantum,Confirmatory,24980054.0,
1308,1181717,1,1,,103172786,5281404,Active,,,19.2,IC50,Antimicrobial activity against promastigote stage of Leishmania infantum,Confirmatory,24980054.0,
1309,1181720,1,1,,103172786,5281404,Active,,,19.2,IC50,Antimicrobial activity against promastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,Confirmatory,24980054.0,
1310,1181721,1,1,,103172786,5281404,Active,,,0.27,IC50,Antimicrobial activity against axenic amastigote stage of Leishmania donovani after 72 hrs by Alamar Blue assay,Confirmatory,24980054.0,
1311,1194597,1,2,,103172786,5281404,Unspecified,131467.0,5770.0,,,Inhibition of PTP1B (unknown origin) assessed as inhibition rate at 100 uM,Other,25819098.0,
1312,1224818,1,1,,312344730,5281404,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
1313,1224819,1,1,,312344730,5281404,Inconclusive,325495545.0,2101.0,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1314,1224820,1,1,,312344730,5281404,Inactive,325495545.0,2101.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1315,1224821,1,1,,312344730,5281404,Inconclusive,325495545.0,2101.0,16.7855,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1316,1224822,1,1,,312344730,5281404,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
1317,1224823,1,1,,312344730,5281404,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1318,1224857,2,1,,312344730,5281404,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1319,1224859,2,1,,90341719,5281404,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1320,1224865,1,2,,49647165,5281404,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1321,1224905,2,1,,121361316,5281404,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1322,1224905,2,1,,121361316,5281404,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1323,1226058,1,1,,103172786,5281404,Active,,,7.33,IC50,Inhibition of L3 larval stage of Onchocerca volvulus chitinase using 4-methylumbelliferyl-N-N'-N''-beta-chitotrioside as substrate assessed as release of 4-methylumbelliferone measured for 10 mins by fluorescence assay,Confirmatory,25815157.0,
1324,1226062,1,1,,103172786,5281404,Inactive,,,,,Mitochondrial uncoupling activity in HEK293T/17 cells at 50 uM after 30 mins by TMRE staining-based fluorescence assay,Other,25815157.0,
1325,1226063,1,1,,103172786,5281404,Inactive,,,,,Antionchocerciasis activity against L3 larval stage of Onchocerca volvulus assessed as inhibition of parasite molting at 10 uM treated for 24 hrs prior to complete medium and PBMC addition measured after 6 days by inverted microscopic analysis,Other,25815157.0,
1326,1226064,1,1,,103172786,5281404,Active,,,,,Antionchocerciasis activity against L3 larval stage of Onchocerca volvulus assessed as prevention of L3 cuticle shedding at 100 uM treated for 24 hrs prior to complete medium and PBMC addition measured after 6 days by inverted microscopic analysis,Other,25815157.0,
1327,1259309,1,1,,125167552,5281404,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
1328,1259310,1,1,,332950238,5281404,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1329,1259310,1,1,,332950470,5281404,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1330,1259310,1,1,,332950751,5281404,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1331,1259311,1,1,,125167552,5281404,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
1332,1259313,1,1,,49647165,5281404,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1333,1259318,1,1,,49647165,5281404,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1334,1259354,1,1,,348412575,5281404,Inconclusive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
1335,1259370,2,2,,124749850,5281404,Inactive,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1336,1259370,2,2,,124749850,5281404,Inactive,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1337,1259370,2,2,,124749850,5281404,Inactive,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1338,1259389,1,1,,124749850,5281404,Active,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1339,1259400,1,1,,49647165,5281404,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1340,1259408,1,1,,363895644,5281404,Active,,,,,GENE-TOX mutagenicity studies,Other,,
1341,1259410,1,1,,363904369,5281404,Unspecified,,,,,CCRIS tumor promotion studies,Other,,
1342,1259415,1,1,,49647165,5281404,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
1343,1259416,1,2,,340086739,5281404,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1344,1259421,1,1,,340086739,5281404,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1345,1259423,1,2,,354768038,5281404,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1346,1259423,1,2,,354917635,5281404,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1347,1259423,1,2,,355001968,5281404,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
